Ocular Oncology

Top Story

Provectus ocular melanoma treatment gets orphan drug designation

February 15, 2019
In the Journals

No survival rate improvement seen after cranio-orbital resection for lacrimal gland carcinoma

January 18, 2019
Local resection with radiotherapy has comparable results with cranio-orbital resection in terms of tumor recurrence and survival rate in patients with lacrimal gland…
Grand Rounds at the New England Eye Center

Woman presents with blurred vision 1 year after cataract surgery

Ocular Surgery News U.S. Edition, January 10, 2019
Adam T. Chin, MD; Shilpa J. Desai, MD; Thomas R. Hedges III, MD
A 65-year-old retired grocery store clerk was referred to the New England Eye Center with more than a year of progressive vision loss in the right eye. Two and a half…
Meeting News

Younger patients with high-risk melanoma benefit from adjuvant Sutent

October 30, 2018
CHICAGO — Sunitinib in the adjuvant setting is associated with greater overall survival in high-risk patients with uveal melanoma, especially younger patients…
More Headlines »
Clinical ScienceOpen Access

A New Suggested Strategy for Safe Injection of Ozurdex

Ophthalmic Surgery, Lasers and Imaging Retina, February 2019, Volume 50 Issue 2
Ozurdex intravitreal injection is performed via a patented injection device. However, there is a common misconception…
More »

Ocular Surface Diseases, Disorders, and Dysfunctions®, Volume 4, Number 3

This activity is supported by an educational grant from Shire.

Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to…
More »
Meeting News Coverage

VIDEO: MRI measures water motion in tissue

August 29, 2016
More »